ADAP - Adaptimmune Therapeutics plc Stock Trading

Adaptimmune Therapeutics plc(NASDAQ: ADAP) stock trading, description, contact, officers and directors.

About Adaptimmune Therapeutics plc

Not available

Stock Information

Adaptimmune Therapeutics plc Company Name:

ADAP Stock Symbol:

NASDAQ Market:

Get ADAP Alerts

News, Short Squeeze, Breakout and More Instantly...

ADAP - Adaptimmune to Report Q2 2021 Financial Results and Business Update on Monday, August 9, 2021

PHILADELPHIA and OXFORDSHIRE, United Kingdom, July 28, 2021 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in cell therapy to treat cancer, will report financial results and provide a business update for the second quarter ended June 30, 2021, after the US markets ...
ADAP - Adaptimmune Therapeutics plc: New 52-Week Low Set Today (ADAP)

Adaptimmune Therapeutics plc (NASDAQ:ADAP) traded today at a new 52-week low of $3.55. This new low was reached on below average trading volume as 263,000 shares traded hands, while the average 30-day volume is approximately 797,000 shares. There is potential upside of 1.2% for shares of...
ADAP - Why Adaptimmune Therapeutics Stock Sank in the First Half of 2021

Shares of Adaptimmune Therapeutics (NASDAQ: ADAP) , a small-cap cancer immunotherapy company, slid by a hefty 21% during the first six months of 2021, according to data from S&P Global Market Intelligence . By contrast, the biotech's shares were among the hottest in the enti...